Pioneering Pain-free Solutions
We leverage the power of medical technology to develop transformative, accurate solutions that improve quality of life.
We are on a mission to redefine the approach to testing and deliver pain-free, accessible solutions that drive transformative change and improve the quality of life.
Our Technology
Revolutionizing Drug Testing Through Fingerprint Sweat Analysis
Our innovative Intelligent Fingerprinting Drug Testing Solution detects commonly abused drugs via sweat from the fingertips. The system’s ease of use and portability make it a convenient solution for reliable drug screening and identification of potential misuse within the 16-24 hours before testing.
Fingerprint DRUG Testing
A Dignified Approach to Drug Testing
Our Intelligent Fingerprinting Drug Screening System tests fingertip sweat for recent drug use, including cannabis, cocaine, opiates, and methamphetamine. Samples are collected in less than one minute and results displayed in less than ten minutes.
Non-invasive Drug Monitoring
SmarTest® Sweat Drug Testing Patch
The SmarTest Patch is a discreet, wearable device that detects drug use through sweat over a 7 to 10-day period. Comfortable, tamper-evident, and water-resistant, it’s ideal for longer-term monitoring in justice and rehabilitation settings.
Used alongside our Intelligent Fingerprinting Drug Screening System, it offers a complete non-invasive sweat-based solution for both immediate and continuous drug detection.
INVESTOR RELATIONS
Transforming Testing Solutions Through Med Tech Innovation
Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. Its Intelligent Fingerprinting Drug Testing Solution is currently being utilized across multiple industries, With recent FDA 510(k) submission in December of 2024 and entry into the US market planned for 2025, INBS is capitalizing on the rapidly growing drug screening products market.
Intelligent Bio Solutions News
Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum
Company anticipates fiscal fourth quarter sequential and year-on-year revenue growth of approximately 16% Company advanced efforts to secure U.S. FDA 510(k) clearance for planned U.S. market entry and strengthened global
Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch
FDA response expected within six weeks; Company remains focused on 2025 U.S. expansion NEW YORK, August 06, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology
Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator
NEW YORK, July 30, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has